Manipulation of the cholinergic system.
Geroldi
C
C
Alzheimer's Unit, IRCCS, Centro S. Giovanni di Dio, Sacro Cuore Fatebenefratelli Hospital, Brescia, Italy.
Bianchetti
A
A
Trabucchi
M
M
D000109:Acetylcholine / Q000502:physiology; D000110:Acetylcholinesterase / Q000502:physiology*; D000368:Aged; D000544:Alzheimer Disease / Q000188:drug therapy / Q000503:physiopathology*; D002540:Cerebral Cortex / Q000187:drug effects / Q000503:physiopathology; D002795:Choline O-Acetyltransferase / Q000502:physiology*; D018678:Cholinergic Agents / Q000627:therapeutic use; D002799:Cholinergic Fibers / Q000187:drug effects / Q000502:physiology*; D002800:Cholinesterase Inhibitors / Q000627:therapeutic use; D006801:Humans; D018721:Muscarinic Agonists / Q000627:therapeutic use; D018727:Muscarinic Antagonists / Q000627:therapeutic use; D009483:Neuropsychological Tests; D011950:Receptors, Cholinergic / Q000187:drug effects / Q000502:physiology*
D018678:Cholinergic Agents; D002800:Cholinesterase Inhibitors; D018721:Muscarinic Agonists; D018727:Muscarinic Antagonists; D011950:Receptors, Cholinergic; D002795:Choline O-Acetyltransferase; D000110:Acetylcholinesterase; D000109:Acetylcholine